Published in Health Care Manag Sci on February 23, 2011
Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer (2012) 2.24
Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer (2009) 3.27
Estimation and projections of cancer prevalence from cancer registry data. Stat Med (2002) 1.75
MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed (1994) 1.13
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol (2011) 4.50
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer (2008) 3.06
Booked inpatient admissions and hospital capacity: mathematical modelling study. BMJ (2002) 2.96
Manufacturing and placing a bespoke support for the Marfan aortic root: description of the method and technical results and status at one year for the first ten patients. Interact Cardiovasc Thorac Surg (2009) 2.72
Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol (2003) 2.59
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol (2008) 2.38
Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev (2005) 2.24
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax (2010) 2.21
Surgical resection of lung cancer England: more operations but no trials to test their effectiveness. Thorax (2012) 2.06
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev (2005) 2.03
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
Providing feedback to hospital doctors about prescribing errors; a pilot study. Pharm World Sci (2007) 1.82
Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer (2006) 1.78
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev (2006) 1.75
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
How many births in sub-Saharan Africa and South Asia will not be attended by a skilled birth attendant between 2011 and 2015? BMC Pregnancy Childbirth (2012) 1.65
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer (2006) 1.64
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res (2010) 1.64
Monitoring risk-adjusted outcomes in congenital heart surgery: does the appropriateness of a risk model change with time? Ann Thorac Surg (2009) 1.60
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. Eur Urol (2007) 1.60
A prospective randomized controlled study to assess the effectiveness of CoSeal® to seal air leaks in lung surgery. Eur J Cardiothorac Surg (2011) 1.60
A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS). Interact Cardiovasc Thorac Surg (2011) 1.50
Using funnel plots to explore variation in cancer mortality across primary care trusts in South-East England. J Public Health (Oxf) (2008) 1.48
The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg (2010) 1.47
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer (2007) 1.43
Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer (2011) 1.38
Estimating attendance for breast cancer screening in ethnic groups in London. BMC Public Health (2010) 1.35
The European Thoracic Surgery Database project: modelling the risk of in-hospital death following lung resection. Eur J Cardiothorac Surg (2005) 1.35
Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg (2007) 1.34
Ethnicity coding in a regional cancer registry and in Hospital Episode Statistics. BMC Public Health (2006) 1.33
Levels of acute health service use among cancer survivors in the United Kingdom. Eur J Cancer (2011) 1.32
High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol (2013) 1.31
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29
Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol (2006) 1.29
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med (2010) 1.24
Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer (2007) 1.23
The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica (2006) 1.23
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22
Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen (2007) 1.21
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. BJU Int (2007) 1.21
Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer (2012) 1.19
MARS: a sense of perspective and an inconvenient truth. J Thorac Oncol (2013) 1.18
Assessment of whether in-hospital mortality for lobectomy is a useful standard for the quality of lung cancer surgery: retrospective study. BMJ (2003) 1.18
A method for early evaluation of a recently introduced technology by deriving a comparative group from existing clinical data: a case study in external support of the Marfan aortic root. BMJ Open (2012) 1.17
The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev (2007) 1.15
Real time monitoring of risk-adjusted paediatric cardiac surgery outcomes using variable life-adjusted display: implementation in three UK centres. Heart (2013) 1.15
Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England. BJU Int (2009) 1.14
Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001. Eur J Cancer Prev (2007) 1.12
IMA Health 2007. Health Care Manag Sci (2008) 1.12
Development of a diagnosis- and procedure-based risk model for 30-day outcome after pediatric cardiac surgery. J Thorac Cardiovasc Surg (2012) 1.09
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer. BJU Int (2009) 1.06
Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract (2006) 1.06
Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax (2012) 1.06
Mortality in relation to early retirement in Denmark: a population-based study. Scand J Public Health (2002) 1.06
Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Control (2006) 1.05
A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open (2014) 1.05
Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer (2007) 1.05
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA. Head Neck (2003) 1.04
Delivering stepped care: an analysis of implementation in routine practice. Implement Sci (2012) 1.04
A technical note concerning non-adherence to drug therapy: exact expressions for the mean and variance of drug concentration. Health Care Manag Sci (2008) 1.04
Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol (2012) 1.03
Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer (2011) 1.03
Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol (2011) 1.02
International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol (2007) 1.01
The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer (2012) 1.01
Histological subtype of lung cancer in relation to socio-economic deprivation in South East England. BMC Cancer (2008) 1.00
Mesothelioma: benefit from surgical resection is questionable. J Thorac Oncol (2007) 0.98
Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open (2012) 0.97
Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health (2009) 0.97
When professional opinion is not enough. BMJ (2007) 0.96
The effect of different comorbidities on survival of non-small cells lung cancer patients. Lung (2014) 0.95
FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients. Lung Cancer (2006) 0.95
Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl (2005) 0.95
Differences in breast cancer hormone receptor status in ethnic groups: a London population. Eur J Cancer (2012) 0.93
Does place of death from cancer vary between ethnic groups in South East England? Palliat Med (2011) 0.93
Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol (2011) 0.93
Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer (2011) 0.92
Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study. Int J Cancer (2014) 0.92
Trends in the treatment of breast cancer in Southeast England following the introduction of national guidelines. J Public Health (Oxf) (2006) 0.92
Socioeconomic and ethnic inequalities in screen-detected breast cancer in London. J Public Health (Oxf) (2013) 0.91
Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open (2012) 0.90
Leaving home after cancer in childhood: a measure of social independence in early adulthood. Pediatr Blood Cancer (2006) 0.90
Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009. Thorax (2013) 0.90
Radiotherapy waiting times for women with breast cancer: a population-based cohort study. BMC Cancer (2007) 0.89
The future burden of cancer in London compared with England. J Public Health (Oxf) (2009) 0.88
Use of diagnostic information submitted to the United Kingdom Central Cardiac Audit Database: development of categorisation and allocation algorithms. Cardiol Young (2012) 0.88
Certified causes of death in patients with mesothelioma in South East England. BMC Cancer (2009) 0.87
DNA methylation gene-based models indicating independent poor outcome in prostate cancer. BMC Cancer (2014) 0.87
Mesothelioma incidence projections in South East England. Eur Respir J (2012) 0.87
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent. Mod Pathol (2010) 0.86
Seeking consensus by formal methods: a health warning. J R Soc Med (2007) 0.86
Rapid assessment of mineral concentration in meadow grasses by near infrared reflectance spectroscopy. Sensors (Basel) (2011) 0.85
Appropriateness of VATS and bedside thoracostomy talc pleurodesis as judged by a panel using the RAND/UCLA appropriateness method (RAM). Interact Cardiovasc Thorac Surg (2006) 0.84